Cytodyne Technologies

A verdict has been found in the class action lawsuit filed against Cytodyne Technologies on behalf of consumers. The court has ordered the company to pay $12,536,820, the amount identified as "obtained by means of unlawful practice." The suit alleged that the companies advertisements for its ephedra-based Xenadrine RFA-1 diet products were deceptive. (May-30-03) [EMAIL LAW FIRM]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no obligation, please click here to fill in our form to submit your complaint.

Add Your Comment on This Issue

Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment: